Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | HP518 |
Trade Name | |
Synonyms | HP 518|HP-518 |
Drug Descriptions |
HP518 is a proteolysis-targeted chimera (PROTAC) that induces degradation of wild-type and mutant forms of the androgen receptor (AR), which potentially induces antitumor activity (J Clin Oncol 2024 42:4_suppl, 124; J Clin Oncol 42 2024 42:16_suppl, 5058). |
DrugClasses | Hormone - Anti-androgens 54 |
CAS Registry Number | NA |
NCIT ID | C204801 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
HP518 | HP518 | 0 | 1 |